Inovio spinout Geneos closes $12M financing round to advance personalized cancer therapy

The Montgomery County biopharmaceutical company's initial target is a type of liver cancer known as advanced hepatocellular carcinoma.

Source: bizjournals.com Health Care:Biotechnology headlines - March 4, 2021 Category: Biotechnology Authors: John George Source Type: news